跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
魏 柏立
教授
,
大腸直腸外科
合聘教授
,
臨床醫學研究所
合聘教授
,
臨床基因體學暨蛋白質體學碩士學位學程
合聘教授
,
細胞治療與再生醫學國際博士學位學程
合聘教授
,
癌症生物學與藥物研發博士學位學程
主治醫師
,
臺北醫學大學附設醫院
成員
,
臺北醫學大學癌症轉譯研究中心
成員
,
臺北醫學大學消化醫學研究中心
https://orcid.org/0000-0002-7275-2661
電子郵件
poliwei
tmu.edu
tw
h-index
4709
引文
37
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1995 …
2024
每年研究成果
概覽
指紋
網路
專案
(17)
研究成果
(214)
資料集
(9)
類似的個人檔案
(12)
指紋
查看啟用 Po-Li Wei 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Colorectal Cancer
57%
Rectum Cancer
51%
Neoplasm
42%
Randomized Controlled Trial
37%
Metastatic Carcinoma
36%
Operation Duration
28%
Colon Cancer
27%
Surgery
27%
Meta-Analysis
26%
Malignant Neoplasm
26%
Laparoscopic Surgery
26%
Appendectomy
23%
Hepatocellular Carcinoma
20%
Cancer Cell
19%
Morbid Obesity
19%
Gastroplasty
18%
Systematic Review
17%
Disease
17%
Quality of Life
16%
Body Mass Index
16%
Breast Cancer
16%
Cancer Growth
15%
Glucose Regulated Protein 94
15%
Minimally Invasive Surgery
14%
Carcinogenesis
12%
Cancer Surgery
12%
Acute Appendicitis
12%
Gastric Banding
12%
Gastric Bypass
12%
Gastric Bypass Surgery
12%
Stoma
12%
Sphincter
11%
Surgeon
11%
Chemoradiotherapy
11%
In Vitro
11%
Rectum Tumor
11%
Colon
11%
Survival Rate
10%
Fluorouracil
10%
Bariatric Surgery
10%
Vermiform Appendix
10%
Carcinoma Cell
10%
Biopsy
10%
Overall Survival
10%
Recurrent Disease
9%
Incision
9%
Open Surgery
9%
Nissen Fundoplication
9%
Postoperative Complication
9%
Learning Curve
9%
Pharmacology, Toxicology and Pharmaceutical Science
Colorectal Cancer
100%
Malignant Neoplasm
66%
Neoplasm
45%
Liver Cell Carcinoma
41%
Colon Cancer
40%
Nicotinic Receptor
30%
Breast Cancer
27%
Carcinogenesis
20%
Cancer Growth
20%
Disease
18%
Metastasis
17%
Chemotherapy
17%
Randomized Controlled Trial
16%
Mouse
16%
Stomach Cancer
15%
Survivin
15%
Glucose Regulated Protein 78
15%
Bevacizumab
15%
Recurrent Disease
14%
Combination Therapy
13%
Catenin
13%
Biological Marker
13%
microRNA
12%
Morbid Obesity
12%
Cetuximab
12%
Fluorouracil
12%
Oxaliplatin
11%
Heat Shock Protein 27
11%
Glucose Regulated Protein 94
11%
Rectum Cancer
11%
Reactive Oxygen Metabolite
11%
Postoperative Pain
11%
Overall Survival
10%
Analgesic Agent
10%
Survival Rate
9%
Gemcitabine
9%
Small Interfering RNA
9%
Fibronectin
9%
Tumor Suppressor Protein
9%
Tumor Growth
9%
Lymph Node Metastasis
8%
Cisplatin
8%
Nicotine-Derived Nitrosamine Ketone
8%
Comorbidity
8%
Wound Healing
8%
Cyclooxygenase 2
8%
Postoperative Complication
7%
Paclitaxel
7%
Curcumin
7%
Chemoradiation Therapy
7%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
60%
Glucose-Regulated Protein
56%
Colon
42%
Cell Migration
25%
MicroRNA
24%
Thrombomodulin
22%
Mesenchymal-Epithelial Transition
19%
Cell Proliferation
19%
Gene Expression
17%
Catenin
17%
Heat Shock Protein
15%
Survivin
15%
Upregulation
14%
Signal Transduction
13%
Carcinogenesis
13%
down Regulation
12%
Autophagy
12%
Tumor Progression
11%
Nicotinic Acetylcholine Receptor
10%
Small Interfering RNA
10%
Cell Growth
10%
Cell Cycle
9%
MTT Assay
8%
Drug Resistance
8%
Cyclooxygenase
8%
Cadherin
8%
Vascular Endothelial Growth Factor
8%
Eicosanoid Receptor
8%
Vimentin
7%
Anticancer
7%
Cancer Stem Cell
7%
Gene Mutation
7%
Aldehyde Dehydrogenase
7%
Estrogen Receptor
7%
Overall Survival
7%
TUNEL Assay
6%
Protein Expression
6%
P53
5%
Next Generation Sequencing
5%
Fluorouracil
5%
Epidermal Growth Factor Receptor
5%
Survival Rate
5%
MMP2
5%
Gelatinase A
5%
Integrin
5%
Real-Time Polymerase Chain Reaction
5%
Fibroblast
5%
Mouse
5%
Tumor Suppressor Protein
5%
Electrospinning
5%
